# Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects

> **NCT03262909** · NA · UNKNOWN · sponsor: **Regentis Biomaterials** · enrollment: 181 (estimated)

## Conditions studied

- Articular Cartilage Defects in the Knee Joint

## Interventions

- **DEVICE:** GelrinC
- **OTHER:** Microfracture historical control arm

## Key facts

- **NCT ID:** NCT03262909
- **Lead sponsor:** Regentis Biomaterials
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-14
- **Primary completion:** 2023-04
- **Final completion:** 2024-11
- **Target enrollment:** 181 (ESTIMATED)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262909, "Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03262909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*